Literature DB >> 29033184

Over expression of HIF1α is associated with inactivation of both LimD1 and VHL in renal cell carcinoma: Clinical importance.

Subhayan Sur1, Arun Kumar Maurya2, Anup Roy3, Tyson V Sharp4, Dilip Kumar Pal2, Chinmay Kumar Panda5.   

Abstract

It is evident that the association of LimD1 and VHL could regulate stabilization of HIF1α protein. In this study, the expression of LimD1, VHL and HIF1α was analyzed in primary renal cell carcinoma (RCC) samples to understand their association with development of the disease. For this purpose, immunohistochemical expression analysis of LimD1, VHL and HIF1α was performed along with proliferation marker PCNA in 32 primary RCC samples in different subtypes at different clinical stages of Indian patients (year: 2014-2016). Significant decrease (P<0.05) in LimD1 and VHL expression was observed in different subtypes of RCC and in early invasive lesions. High nuclear expression of HIF1α was seen in different subtypes as well as in early invasive lesions. The LimD1 and VHL expression strongly correlated with each other, while inversely correlated with HIF1α. On the other hand, increased expression of PCNA was seen in different sub types and in early invasive lesions. The PCNA expression was negatively correlated with LimD1 and VHL expression and positively correlated with HIF1α. Thus, our data indicates that the reduced expression of LimD1 and VHL might have synergistic effect on induction of HIF1α resulting increased cellular proliferation and progression of the disease.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  HIF1α; LimD1; PCNA; Renal cell carcinoma; VHL

Mesh:

Substances:

Year:  2017        PMID: 29033184     DOI: 10.1016/j.prp.2017.10.009

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Energy stress-induced lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and inhibits osteosarcoma progression.

Authors:  Yao Kang; Xiaojun Zhu; Yanyang Xu; Qinglian Tang; Zongwen Huang; Zhiqiang Zhao; Jinchang Lu; Guohui Song; Huaiyuan Xu; Chuangzhong Deng; Jin Wang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

2.  Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study.

Authors:  Shreya Sarkar; Neyaz Alam; Syam Sundar Mandal; Kabita Chatterjee; Supratim Ghosh; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

3.  Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes.

Authors:  Kathryn Davidson; Paul Grevitt; Maria F Contreras-Gerenas; Katherine S Bridge; Miguel Hermida; Kunal M Shah; Faraz K Mardakheh; Mark Stubbs; Rosemary Burke; Pedro Casado; Pedro R Cutillas; Sarah A Martin; Tyson V Sharp
Journal:  Cell Death Dis       Date:  2021-11-11       Impact factor: 8.469

4.  MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL.

Authors:  Wei Zou; Jun Cheng
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.